Emmes – a full-service, global Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation – in collaboration with the UC Davis Eye Center, helped coordinate the largest study of its kind using autologous CD34+ stem cells to treat vision loss caused by central retinal vein occlusion (CRVO), a common and often debilitating retinal vascular disease. […]
Post Type Archives: News
Sygnature Discovery Unveils Strategic Rebrand to Cement Status as a Global Drug Discovery Partner
Sygnature Discovery, a leading drug discovery contract research organisation (CRO), has today announced a strategic brand relaunch, including a new website, cementing its position as a global drug discovery partner. For more than 20 years, Sygnature has built a strong reputation for delivering high quality candidates. Continued investment and strategic acquisitions have enabled the company […]
Changes to the Composition of the Lonza Board
Today, the Lonza Board of Directors announced the nomination of Sami Atiya as an Independent Member of the Board. The Board will propose Sami’s election to shareholders at the Lonza Group Annual General Meeting (AGM) in May 2026. Subject to his election at the AGM, Sami will also be appointed a member of the Strategy […]
Nanoform – Subcutaneously administered Nanotrastuzumab matches performance of Herceptin HYLECTA in minipig study
Nanoform Finland Plc, the medicine performance-enhancing company, announced the results from a preclinical study designed to compare the tolerability and pharmacokinetics of Nanotratsuzumab, a nanoformed, novel, hyaluronidase-free, non-aqueous nanoparticle suspension of trastuzumab for subcutaneous delivery versus Herceptin HYLECTATM 1, a co-formulated product with Halozyme’s proprietary hyaluronidase enzyme marketed by Roche/Genentech. Subcutaneous delivery of monoclonal antibodies, […]
Syngene Collaborates with Johns Hopkins University to Advance Early-Stage Drug Discovery
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early‑stage drug discovery programs and platform technologies emerging from the university’s research labs. The collaboration will be delivered by Syngene SynVent™, a fully integrated drug discovery and development platform that spans discovery […]
FUJIFILM Biotechnologies Unveils Biomanufacturing and Process Development Expansion in the United Kingdom
FUJIFILM Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing innovative medicines and vaccines in the United Kingdom. TEESSIDE, United Kingdom, February 11, 2026 – FUJIFILM Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, celebrated the grand opening of […]
Azenta and Frontier Space Partner to Advance Space-Based Life Sciences Research
Azenta Life Sciences, a global provider of life sciences solutions, and Frontier Space, a space biotech company advancing in-space biomanufacturing, research, and development, announced a research partnership on February 9th, 2026. The collaboration includes participation in the recently launched Early Gen Micro-Gravity Service (EGGS-2) mission, which is designed to evaluate life science technologies in a […]
Lilly to Acquire Orna Therapeutics for $2.4 Billion
Eli Lilly and Company announced plans to acquire Orna Therapeutics, a biotechnology company engineering immune cells in vivo, on February 9th, 2026. The deal is valued at up to $2.4 billion, including an upfront payment and clinical milestone payments. According to a company press release, Orna’s lead candidate is ORN-252, a clinical trial-ready, CD-19 targeting […]
Helsinn and ESTEVE expand their partnership extending the Distribution and Licence Agreement for AKYNZEO® and ALOXI® to Austria
Helsinn Healthcare SA (“Helsinn”), a global pharmaceutical group focused on supporting patients with cancer and chronic diseases, and ESTEVE, an international pharma company with a focus on highly specialized treatments that address significant unmet medical needs, today announced that they have expanded their relationship by extending the Distribution and Licence Agreement for AKYNZEO® (combination of […]
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays
Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug discovery, development, testing, and manufacturing solutions provider. Under the collaboration, Charles River will give its clients access to Synthace’s transformative approach to developing, automating and transferring more robust assays, […]